
Associate Professor Dorit Samocha-Bonet
After completing a BSc (Cum Laude) degree in Nutritional Sciences at the Hebrew University (Israel) in 1992, Associate Professor Dorit Samocha-Bonet joined the Nutrition and Dietetics Department at Tel Aviv Medical Center as a clinical dietician. In 1996 she completed a MSc (with Honours) in Clinical Biochemistry at Tel Aviv University (Israel).
As a clinical dietician, Dorit noted the fact that only a minority of her patients could maintain a reduced healthy weight in the long term, and she decided to turn to research into obesity and metabolic disease. After the birth of her second child, she embarked on a PhD in medical science.
After completing a PhD in Physiology and Pharmacology at Tel Aviv University (Israel) in 2006, she relocated to Sydney in 2007 where she took a postdoctoral position at the Diabetes & Metabolism Division at the Garvan Institute of Medical Research. In 2013 she established the Clinical Insulin Resistance group. She is a Council member and Secretary of the Australian New Zealand Obesity Society, a body striving to improve the management of people living with obesity, fight stigma and prevent obesity through advocacy.
Awards
- 2022
UNSW Education Innovation Award for the design of four new bachelor / masters health professional programs
- 2021
UNSW Head of School Award for Outstanding Contribution to Health Sciences
- 2018
Award for contribution to early-career peers and postgraduate students - Garvan Institute of Medical Research
- 2016
Top ranked grant application from the Diabetes Australia Research Program (Australian Diabetes Society)
- 2011
Skip Martin Early Career Fellow (Australian Diabetes Society)
Selected publications
See all publications- PUBLISHED 23 March 2026Nature Medicine
Diet-microbiome associations in 10,068 individuals from the Human Phenotype Project to guide personalized nutrition
- PUBLISHED 14 January 2026Nature
A foundation model for continuous glucose monitoring data
- PUBLISHED 1 January 2026Diabetes Care
Tirzepatide in Adults With Type 1 Diabetes: A Phase 2 Randomized Placebo-Controlled Clinical Trial
- PUBLISHED 24 November 2025Nature Communications
Effect of metformin on insulin resistance in adults with type 1 diabetes: a 26-week randomized double-blind clinical trial
- PUBLISHED 11 July 2025Crohn's & Colitis 360
Oral Microbial Diversity is Associated with Biologic Treatment and Metabolic Health Status but not with Disease Activity in Patients with Inflammatory Bowel Disease
